Maria Fusaro, Simona Barbuto, Maurizio Gallieni, Althea Cossettini, Giulia Vanessa Re Sartò, Laura Cosmai, Giuseppe Cianciolo, Gaetano La Manna, Thomas Nickolas, Serge Ferrari, Jordi Bover, Mathias Haarhaus, Carmela Marino, Maria Cristina Mereu, Maura Ravera, Mario Plebani, Martina Zaninotto, Mario Cozzolino, Stefano Bianchi, Piergiorgio Messa, Mariacristina Gregorini, Lorenzo Gasperoni, Caterina Agosto, Andrea Aghi, Giovanni Tripepi
BACKGROUND: Chronic kidney disease mineral bone disorder (CKD-MBD) is a condition characterized by alterations of calcium, phosphate, parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF-23) metabolism that in turn promote bone disorders, vascular calcifications, and increase cardiovascular (CV) risk. Nephrologists' awareness of diagnostic, prognostic, and therapeutic tools to manage CKD-MBD plays a primary role in adequately preventing and managing this condition in clinical practice...
January 2024: Clinical Kidney Journal